Clinical Trials on Symptomatic Hypertrophic Cardiomyopathy (HCM) in Japan
Total 7 results
-
Bristol-Myers SquibbRecruitingHypertrophic CardiomyopathyJapan
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, Hypertrophic ObstructiveJapan
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, HypertrophicSpain, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Hungary, Israel, Japan, Netherlands, Norway, Poland, Portugal, United Kingdom, United States, Australia, China, Czechia, India, Italy, Korea, Republic of
-
Alexion Pharmaceuticals, Inc.Eidos Therapeutics, a BridgeBio companyActive, not recruitingSymptomatic Transthyretin Amyloid CardiomyopathyJapan
-
Hiroaki Shimokawa, MD, PhDUnknownHeart Failure | Coronary Disease | Heart Valve Diseases | Cardiomyopathies | Left Ventricular HypertrophyJapan
-
Novo Nordisk A/SActive, not recruitingTransthyretin Amyloid Cardiomyopathy (ATTR CM)United States, Netherlands, Spain, Portugal, Canada, Czechia, France, Germany, Italy, Japan
-
Ionis Pharmaceuticals, Inc.Active, not recruitingTransthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)United States, Australia, Spain, Canada, Germany, Japan, Italy, Israel, Argentina, France, Portugal, Austria, Brazil, Greece, United Kingdom, Czechia, Sweden, Belgium, Denmark, Poland, Puerto Rico